By Maitane Sardon
Shares in Lanxess fell after the German specialty-chemicals company revised its full-year outlook and posted weaker-than-expected results for its operating segments.
Lanxess reported adjusted earnings before interest, taxes, depreciation, and amortization of 125 million euros ($143.7 million), in line with analysts' expectations.
Shares were 11% lower at 17.32 euros in European morning trade Thursday.
The result was propped up by the Others line and one-time bonus reversals, not by the underlying operations, Citi analysts said in a research note. All operating segments missed consensus expectations, the analysts said.
The company said it now expects full-year adjusted Ebitda to be at the low end of a range of between 520 million and 580 million euros. Consensus expects Ebitda at 522 million euros and achieving the new target requires less seasonality than usual, which could be challenging, the analysts added.
Write to Maitane Sardon at maitane.sardon@wsj.com
(END) Dow Jones Newswires
November 06, 2025 05:22 ET (10:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments